Literature DB >> 18357532

T-cell non-Hodgkin's lymphoma presenting after clearance of hepatitis C: a case report and review of the literature.

Sindu Stephen1, Marie Borum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18357532     DOI： 10.1007/s10620-007-0037-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  14 in total

1.  High prevalence of HCV infection in patients with B-cell non-Hodgkin's lymphoma: comparison with birth cohort- and sex-matched blood donors in a Japanese population.

Authors:  Yasuharu Imai; Masahiko Ohsawa; Hideo Tanaka; Shinji Tamura; Hiroyuki Sugawara; Jun Kuyama; Kazuto Fukuda; Takeshi Yonezawa; Yuji Matsuzawa; Yuji Matszawa
Journal:  Hepatology       Date:  2002-04       Impact factor: 17.425

2.  Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma.

Authors:  E Zuckerman; T Zuckerman; A M Levine; D Douer; K Gutekunst; M Mizokami; D G Qian; M Velankar; B N Nathwani; T L Fong
Journal:  Ann Intern Med       Date:  1997-09-15       Impact factor: 25.391

3.  bcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infection.

Authors:  E Zuckerman; T Zuckerman; D Sahar; S Streichman; D Attias; E Sabo; D Yeshurun; J Rowe
Journal:  Br J Haematol       Date:  2001-02       Impact factor: 6.998

4.  Essential mixed cryoglobulinemia, type II: a manifestation of a low-grade malignant lymphoma? Clinical-morphological study of 12 cases with special reference to immunohistochemical findings in liver frozen sections.

Authors:  A Monteverde; M T Rivano; G C Allegra; A I Monteverde; P Zigrossi; P Baglioni; M Gobbi; B Falini; G Bordin; S Pileri
Journal:  Acta Haematol       Date:  1988       Impact factor: 2.195

5.  Binding of hepatitis C virus to CD81.

Authors:  P Pileri; Y Uematsu; S Campagnoli; G Galli; F Falugi; R Petracca; A J Weiner; M Houghton; D Rosa; G Grandi; S Abrignani
Journal:  Science       Date:  1998-10-30       Impact factor: 47.728

6.  A role for hepatitis C virus infection in type II cryoglobulinemia.

Authors:  V Agnello; R T Chung; L M Kaplan
Journal:  N Engl J Med       Date:  1992-11-19       Impact factor: 91.245

7.  Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis.

Authors:  Javier P Gisbert; Luisa García-Buey; José María Pajares; Ricardo Moreno-Otero
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

8.  Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection.

Authors:  Olivier Hermine; François Lefrère; Jean-Pierre Bronowicki; Xavier Mariette; Katayoun Jondeau; Virginie Eclache-Saudreau; Béatrice Delmas; Françoise Valensi; Patrice Cacoub; Christian Brechot; Bruno Varet; Xavier Troussard
Journal:  N Engl J Med       Date:  2002-07-11       Impact factor: 91.245

9.  Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia.

Authors:  M Luppi; M Grazia Ferrari; G Bonaccorsi; G Longo; F Narni; P Barozzi; R Marasca; C Mussini; G Torelli
Journal:  Leukemia       Date:  1996-02       Impact factor: 11.528

10.  Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders.

Authors:  F Silvestri; C Pipan; G Barillari; F Zaja; R Fanin; L Infanti; D Russo; E Falasca; G A Botta; M Baccarani
Journal:  Blood       Date:  1996-05-15       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.